The miR-17 family (including miR-17, 20a, 20b) can repress TGFβR2, a core receptor of the TGFβ signal pathway, and reverse cisplatin-resistance in NSCLC (Jiang et al., 2014). Here, TGFB1 is linked to non-small cell lung carcinoma.